Dr. Petr Franklin Boshinski, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 307 Boatner Rd Ste 114, Eglin Afb, FL 32542 Phone: 850-883-8132 |
Katelin Staley, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 307 Boatner Rd, Eglin Afb, FL 32542 Phone: 850-883-9470 |
Dr. Darrell Scott Grise, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 307 Boatner Rd, Suite 114, Eglin Afb, FL 32542 Phone: 850-883-9472 Fax: 850-883-1267 |
Dr. Tina Dang Aldana, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 307 Boatner Rd Ste 114, Eglin Afb, FL 32542 Phone: 850-883-8600 |
News Archive
Kaiser Health News consumer columnist Michelle Andrews writes: "How much leeway do employers and insurers have in deciding whether they'll cover contraceptives without charge and in determining which methods make the cut? Not much, as it turns out, but that hasn't stopped some from trying. Kaiser Health News readers still write in regularly describing battles they're waging to get the birth control coverage they're entitled to" (Andrews, 8/22).
Genmab announced today the US Food and Drug Administration (FDA) accepted its Investigational New Drug Application (IND) to start a Phase I/II dose escalation trial for HuMax-CD20 to treat patients with active rheumatoid arthritis (RA) who have failed one treatment with one or more disease modifying anti-rheumatic drugs (DMARDs).
Over 86% of Australia's professional workers have deliberately ignored or snubbed a colleague at work at least once, according to the findings of a new study by SACS Consulting into counter-productive workplace behaviours (CWBs) announced today.
A new study evaluates the best option in terms of weight loss surgery for those who need it. Researchers found gastric bypass patients lose more weight than gastric banding patients and keep it off longer. Even though banding is a simpler operation, nearly half of those patients were still obese after six years.
Cutting edge, patient-specific vaccine treatments like DCVax® provide for a longer life expectancy along with a better quality of life for brain cancer patients, an improvement over current conventional brain tumor treatments. "The vaccine that I received has extended the median survival of Grade IV brain cancer (GBM) from 14.6 months, with conventional treatment, to over 36 months," stated Bob Gibbs, a 7 year brain cancer survivor, who has defied the odds statistically, thanks to the experimental brain cancer vaccine DCVax®.
› Verified 2 days ago